HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $82.30 billion. The enterprise value is $127.18 billion.
| Market Cap | 82.30B |
| Enterprise Value | 127.18B |
Important Dates
The last earnings date was Friday, October 25, 2024, before market open.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Dec 13, 2024 |
Share Statistics
HCA Healthcare has 253.30 million shares outstanding. The number of shares has decreased by -5.09% in one year.
| Current Share Class | 253.30M |
| Shares Outstanding | 253.30M |
| Shares Change (YoY) | -5.09% |
| Shares Change (QoQ) | -1.57% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 64.54% |
| Float | 180.46M |
Valuation Ratios
The trailing PE ratio is 14.56 and the forward PE ratio is 13.61. HCA Healthcare's PEG ratio is 1.09.
| PE Ratio | 14.56 |
| Forward PE | 13.61 |
| PS Ratio | 1.22 |
| Forward PS | 1.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.00 |
| P/OCF Ratio | 7.74 |
| PEG Ratio | 1.09 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.25, with an EV/FCF ratio of 21.63.
| EV / Earnings | 21.45 |
| EV / Sales | 1.83 |
| EV / EBITDA | 9.25 |
| EV / EBIT | 12.11 |
| EV / FCF | 21.63 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 57.11.
| Current Ratio | 1.12 |
| Quick Ratio | 0.87 |
| Debt / Equity | 57.11 |
| Debt / EBITDA | 3.04 |
| Debt / FCF | 7.63 |
| Interest Coverage | 5.19 |
Financial Efficiency
Return on equity (ROE) is 1,195.45% and return on invested capital (ROIC) is 15.06%.
| Return on Equity (ROE) | 1,195.45% |
| Return on Assets (ROA) | 11.51% |
| Return on Capital (ROIC) | 15.06% |
| Revenue Per Employee | $224,584 |
| Profits Per Employee | $19,126 |
| Employee Count | 310,000 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 21.74 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.90 billion in taxes.
| Income Tax | 1.90B |
| Effective Tax Rate | 21.79% |
Stock Price Statistics
The stock price has increased by +30.73% in the last 52 weeks. The beta is 1.69, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +30.73% |
| 50-Day Moving Average | 379.41 |
| 200-Day Moving Average | 346.36 |
| Relative Strength Index (RSI) | 24.73 |
| Average Volume (20 Days) | 1,619,535 |
Short Selling Information
The latest short interest is 2.60 million, so 1.02% of the outstanding shares have been sold short.
| Short Interest | 2.60M |
| Short Previous Month | 2.68M |
| Short % of Shares Out | 1.02% |
| Short % of Float | 1.44% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $69.62 billion and earned $5.93 billion in profits. Earnings per share was $22.31.
| Revenue | 69.62B |
| Gross Profit | 28.25B |
| Operating Income | 10.50B |
| Pretax Income | 7.57B |
| Net Income | 5.93B |
| EBITDA | 13.75B |
| EBIT | 10.50B |
| Earnings Per Share (EPS) | $22.31 |
Balance Sheet
The company has $2.98 billion in cash and $44.89 billion in debt, giving a net cash position of -$41.91 billion or -$165.44 per share.
| Cash & Cash Equivalents | 2.98B |
| Total Debt | 44.89B |
| Net Cash | -41.91B |
| Net Cash Per Share | -$165.44 |
| Equity (Book Value) | 786.00M |
| Book Value Per Share | -8.57 |
| Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was $10.63 billion and capital expenditures -$4.75 billion, giving a free cash flow of $5.88 billion.
| Operating Cash Flow | 10.63B |
| Capital Expenditures | -4.75B |
| Free Cash Flow | 5.88B |
| FCF Per Share | $23.21 |
Margins
Gross margin is 40.58%, with operating and profit margins of 15.08% and 8.52%.
| Gross Margin | 40.58% |
| Operating Margin | 15.08% |
| Pretax Margin | 12.55% |
| Profit Margin | 8.52% |
| EBITDA Margin | 19.75% |
| EBIT Margin | 15.08% |
| FCF Margin | 7.15% |
Dividends & Yields
This stock pays an annual dividend of $2.64, which amounts to a dividend yield of 0.81%.
| Dividend Per Share | $2.64 |
| Dividend Yield | 0.81% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 11.83% |
| Buyback Yield | 5.09% |
| Shareholder Yield | 5.90% |
| Earnings Yield | 7.20% |
| FCF Yield | 7.14% |
Analyst Forecast
The average price target for HCA Healthcare is $393.08, which is 20.97% higher than the current price. The consensus rating is "Buy".
| Price Target | $393.08 |
| Price Target Difference | 20.97% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 5.82% |
| EPS Growth Forecast (5Y) | 10.28% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.59 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.59 |
| Piotroski F-Score | 6 |